We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$38.5M
5VM
2
5AM Venture Management
California
$26.9M
VC
3
Vivo Capital
California
$26.9M
VP
4
venBio Partners
California
$25.7M
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.79M -$131K -17,916 -3%
DA
6
DCF Advisers
Connecticut
$4.09M +$522K +71,508 +19%
LM
7
Lasry Marc
$3.81M +$572K +78,329 +24%
OM
8
Opaleye Management
Massachusetts
$1.35M +$1.06M +144,642 New
Millennium Management
9
Millennium Management
New York
$1.34M +$1.05M +144,207 New
GGHC
10
Gilder Gagnon Howe & Co
New York
$1.28M +$1M +137,394 New
LCM
11
Laurion Capital Management
New York
$1.16M +$912K +124,800 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.07M -$340K -46,604 -29%
BlackRock
13
BlackRock
New York
$908K -$1.81M -248,201 -72%
BCM
14
Bridgeway Capital Management
Texas
$730K
State Street
15
State Street
Massachusetts
$389K -$1.01M -138,345 -77%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$327K -$95.8K -13,107 -27%
E
17
Ergoteles
New York
$265K +$207K +28,400 New
EP
18
EPIQ Partners
Minnesota
$174K
Renaissance Technologies
19
Renaissance Technologies
New York
$160K -$117K -16,000 -48%
Morgan Stanley
20
Morgan Stanley
New York
$145K +$33.3K +4,554 +41%
Goldman Sachs
21
Goldman Sachs
New York
$133K +$10.8K +1,484 +12%
BJL
22
Brighton Jones LLC
Washington
$132K -$511 -70 -0.5%
TFS
23
TrustCore Financial Services
Tennessee
$125K
Northern Trust
24
Northern Trust
Illinois
$95K -$291K -39,765 -80%
LC
25
Lindbrook Capital
California
$28K